Ascentage Pharma Group International
HKEX:6855

Watchlist Manager
Ascentage Pharma Group International Logo
Ascentage Pharma Group International
HKEX:6855
Watchlist
Price: 50.15 HKD 0.1% Market Closed
Market Cap: 17.5B HKD

Wall Street
Price Targets

Price Targets Summary
Ascentage Pharma Group International

Wall Street analysts forecast Ascentage Pharma Group International stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 54.43 HKD with a low forecast of 52.52 HKD and a high forecast of 57.75 HKD.

Lowest
Price Target
52.52 HKD
5% Upside
Average
Price Target
54.43 HKD
9% Upside
Highest
Price Target
57.75 HKD
15% Upside
Ascentage Pharma Group International Competitors:
Price Targets
MDGL
Madrigal Pharmaceuticals Inc
56% Upside
BPMC
Blueprint Medicines Corp
26% Upside
603087
Gan & Lee Pharmaceuticals
14% Upside
LGND
Ligand Pharmaceuticals Inc
43% Upside
IVACC
Intervacc AB
572% Upside
MAB
Mabion SA
13% Downside
086890
Isu Abxis Co Ltd
88% Upside
688331
RemeGen Co Ltd
34% Downside

Revenue
Forecast

Revenue Estimate
Ascentage Pharma Group International

For the last 7 years the compound annual growth rate for Ascentage Pharma Group International's revenue is 106%. The projected CAGR for the next 3 years is 19%.

106%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ascentage Pharma Group International

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascentage Pharma Group International

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ascentage Pharma Group International's stock price target?
Price Target
54.43 HKD

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 54.43 HKD with a low forecast of 52.52 HKD and a high forecast of 57.75 HKD.

What is Ascentage Pharma Group International's Revenue forecast?
Projected CAGR
19%

For the last 7 years the compound annual growth rate for Ascentage Pharma Group International's revenue is 106%. The projected CAGR for the next 3 years is 19%.

Back to Top